NCT01807000View on ClinicalTrials.gov

Absorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled Prucalopride Succinate in Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 18, 2013

Primary Completion Date

April 28, 2013

Study Completion Date

April 28, 2013

Conditions
Healthy
Interventions
DRUG

Radiolabeled Prucalopride Succinate

A single oral dose of 2 mg radiolabeled prucalopride succinate administered on Day 1.

Trial Locations (1)

53704

Covance Global Clinical Research Unit Inc., Madison

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
lead

Shire

INDUSTRY

NCT01807000 - Absorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled Prucalopride Succinate in Volunteers | Biotech Hunter | Biotech Hunter